Back to search

Article

Gene Therapy Mediates Therapeutic Improvement in Cardiac Hypertrophy and Survival in a Murine Model of <i>MYBPC3</i> -Associated Cardiomyopathy

2024-02-23

Abstract excerpt

<h4>Background</h4> Hypertrophic cardiomyopathy (HCM) affects an estimated 600,000 people in the U.S. and is the leading cause of sudden cardiac arrest in those under 18. Loss-of-function mutations in Myosin Binding Protein C3 , MYBPC3 , are the most common genetic cause of HCM. The majority of MYBPC3 mutations causative for HCM result in truncations. The sarcomeric pathophysiology of the majority of HCM patie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
598e0c1b-76f0-5df4-928c-be1020b5b143
DOI
10.1101/2024.02.19.581102
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gene Therapy Mediates Therapeutic Improvement in Cardiac Hypertrophy and Survival in a Murine Model of <i>MYBPC3</i> -Associated CardiomyopathyDOI 10.1101/2024.02.19.581102
Select a neighboring publication to make it the new centre.